contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


ortivus-announces-mandatory-public-offer-from-ponderus-invest-ab

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Ortivus is engaged in the health care sector. The company specializes in the development of mobile solutions. The services include, for example, monitoring and communication solutions that are further used in decision-making and support systems. Today, the solutions are resold under various brands. The largest business operations are held in the Nordic region, and Europe. Ortivus was established in 1985 and is headquartered in Danderyd.

Ortivus

On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus...

<div class="mfn-preamble"><p><strong>On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB (“Ortivus”) in accordance with the Takeover Rules for certain trading platforms adopted by the Swedish Securities Council. Today, on 2 December 2025, Ponderus Invest AB submitted such a mandatory public offer to the shareholders of Ortivus (the “Offer”). Under the terms of the Offer, Ponderus Invest AB is offering 1,22 SEK per A share and per B share. The full Offer from Ponderus Invest AB is available at </strong><strong><a rel="noopener" href="https://www.ponderusinvest.se">https://www.ponderusinvest.se</a></strong><strong>.</strong></p></div><div class="mfn-body"><p>The acceptance period for the Offer is expected to commence on or around 15 December 2025 and is expected to end on or around 12 January 2026.</p><p>The Board of Directors of Ortivus has appointed an independent bid committee, consisting of the board members Anna-Carin Strandberg, Ulf Järnberg, and Anna Klevby Dalgaard, to handle matters relating to the Offer. The board member Peter Edwall is considered to have a conflict of interest, as he indirectly owns approximately 97% of the shares in Ponderus Invest AB and is the sole board member of Ponderus Invest AB. Peter Edwall has therefore not participated, and will not participate, in the Board’s handling of matters concerning the Offer.</p><p>The independent bid committee will evaluate the Offer and obtain an independent fairness opinion. The committee will present its view on the Offer in accordance with applicable regulations well in advance of the expiry of the acceptance period.</p><p>For more information from Ortivus view <a rel="noopener" href="https://ortivus.com/investors/mandatory-public-offer-disclaimer/">https://ortivus.com/investors/mandatory-public-offer-2025/</a></p></div><div class="mfn-footer mfn-contacts mfn-060ef24c5677"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>For further information, please contact</p><p>Gustaf Nordenhök, CEO</p><p>Phone +46 8 446 45 00</p></div><div class="mfn-footer mfn-about mfn-92fa32462855"><p><strong class="mfn-heading-1">About Ortivus</strong></p><hr><p>Ortivus has extensive experience in mobile communication solutions and a unique understanding of clinical healthcare. We develop interactive and user-friendly solutions that support diagnostics, increase efficiency, and deliver long-term cost savings for healthcare providers. By integrating our solutions with electronic health records, dispatch systems, and national registries, we ensure fast and secure information management, a crucial factor in creating a more integrated care process.&nbsp;<br>&nbsp;<br>Our solutions save valuable time for healthcare professionals, optimise resource use, and reduce the need for avoidable patient transports, resulting in more cost-effective and patient-centred care. With our combination of advanced technology and deep clinical expertise, we support our customers in meeting the healthcare challenges of today and tomorrow.</p><p>Ortivus Class A and Class B shares are listed on the NASDAQ First North Growth Market and the company’s Certified Adviser is FNCA Sweden AB.<br>&nbsp;<br>Read more about our solutions at <a rel="noopener" href="http://www.ortivus.com/">www.ortivus.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/9d6f8f01-68e6-433b-9434-e331b9098fe2/ortivus-announces-mandatory-public-offer-from-ponderus-invest-ab.pdf" class="mfn-generated mfn-primary">Ortivus announces mandatory public offer from Ponderus Invest AB</a></p></div>